Subtle Medical

About:

Subtle Medical utilizes AI to enhance various imaging processes, such as PET and MRI scans, improving both speed and quality.

Website: https://subtlemedical.com

Twitter/X: SubtleMedical

Top Investors: Bessemer Venture Partners, National Institutes of Health, DCVC, SAV (Scale Asia Ventures), Samsung Ventures

Description:

Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow. The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant to facilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers. Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.

Total Funding Amount:

$59.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2017-08-01

Contact Email:

info(AT)subtlemedical.com

Founders:

Enhao Gong, Greg Zaharchuk

Number of Employees:

11-50

Last Funding Date:

2024-09-04

IPO Status:

Private

© 2024 MyAiNote.com